1234996-74-7 Usage
Uses
Used in Pharmaceutical Development:
(R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride is utilized as a key intermediate in the synthesis of various pharmaceutical drugs due to its potential pharmacological properties. (R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride's structural features allow it to be a versatile building block for the creation of new therapeutic agents.
Used in Antimicrobial Agents:
In the field of antimicrobials, (R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride is used as a precursor for developing new antibiotics, leveraging the antimicrobial activity often associated with benzimidazole derivatives. Its ability to target and disrupt bacterial processes makes it a promising candidate for combating resistant strains of bacteria.
Used in Antiparasitic Medications:
(R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride is employed as a component in antiparasitic medications, capitalizing on the antiparasitic effects of benzimidazole compounds. It may be used to treat infections caused by various parasites by interfering with their vital cellular processes.
Used in Antitumor Therapies:
In oncology, (R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride is used as a starting material for the design of antitumor agents. Its potential to exhibit antitumor activity makes it a candidate for further research into treatments for various types of cancer.
Used in Research Compounds:
Within the research community, (R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride serves as a research compound for studying the effects of benzimidazole derivatives on biological systems. It aids scientists in understanding the mechanisms of action and potential applications in medicine.
Used in Drug Delivery Systems:
(R)-1-(1H-Benzimidazol-2-yl)ethylamine Hydrochloride may also be used in the development of drug delivery systems to improve the bioavailability and targeting of therapeutic agents, particularly for those derived from benzimidazole chemistry, enhancing their efficacy and reducing side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1234996-74-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,4,9,9 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1234996-74:
(9*1)+(8*2)+(7*3)+(6*4)+(5*9)+(4*9)+(3*6)+(2*7)+(1*4)=187
187 % 10 = 7
So 1234996-74-7 is a valid CAS Registry Number.
1234996-74-7Relevant articles and documents
BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS
-
Page/Page column 30-31, (2008/06/13)
The present invention provides compounds having formula (I) wherein n, p, q and r are each independently selected from 0 or 1; a, b, c, and d each independently represents a carbon or nitrogen atom, with the proviso that no more than two of a, b, c, and d are nitrogen atoms; Y and Y' each independently represents 1-4 optional substituents selected from alkyl, alkoxy, halo, -CF3, and -C(O)OH; R, R, R and R are H or specified substituents; R, R, R, R, R, R, R and R are independently selected from H or C1-C3 alkyl; or a biolabile ester thereof, or a pharmaceutically acceptable salt thereof. Also provided are methods of using these compounds for treating vitronectin-mediated disorders, e.g., cancer, retinopathy, artherosclerosis, vascular restenosis, and osteoporosis.
